Choose which categories of cookies you allow. Strictly necessary cookies are always on.
Required for core site functionality, security and your session. Always active.
Help us understand how visitors use the site (e.g. Google Analytics) so we can improve it.
Used to measure campaigns and show you relevant ads on other sites (e.g. LinkedIn, Google Ads).
|
Sr. No. |
Item |
Description |
|
1 |
Company Name |
Stryker Corporation |
|
2 |
Website |
www.stryker.com |
|
3 |
Established Date |
1941 |
|
4 |
Headquartered |
United States |
|
5 |
Market Position/ History |
Stryker Corporation was founded in 1941 by Dr. Homer Stryker, an orthopaedic surgeon from Kalamazoo, Michigan, after inventing innovative medical devices to improve patient care. Initially known as The Orthopedic Frame Company, it became Stryker Corporation in 1964. Early innovations included the Wedge Turning Frame and oscillating saw, which revolutionized patient care. The company expanded throughout the decades, entering new markets like orthopaedic implants, endoscopy, and surgical navigation. By the 1990s, Stryker grew through major acquisitions, including Howmedica, and entered the robotic surgery field in the 2000s with the acquisition of MAKO Surgical. Under leadership changes, including Stephen MacMillan and Kevin Lobo, Stryker continued its growth through acquisitions like K2M Group, expanding its presence in spine and neurotechnology. The company exceeded $10 billion in sales by 2016 and continues to lead in medical innovation, with a focus on improving healthcare outcomes, reflecting Dr. Stryker's legacy of ingenuity and care. |
|
6 |
Sales Area |
Worldwide |
|
7 |
Ticker |
NYSE: SYK |
|
8 |
No. of Employees |
~52000 |
|
9 |
Competitors |
|
|
10 |
CEO |
Kevin Lobo |
|
11 |
Ownership Type |
Public |
|
12 |
Contact Information |
1941 Stryker Way, Portage, MI 49002, USA Tel: +1 269 385 2600 |
Medical Surgical Equipment
Stryker’s Medical Surgical Equipment segment is centered on advancing healthcare delivery by providing innovative, performance-driven solutions that span the entire continuum of care. The company is committed to improving outcomes for both patients and caregivers through thoughtfully designed equipment that prioritizes safety, efficiency, and clinical effectiveness.
This segment supports healthcare environments from emergency medical services (EMS) through to the operating room (OR), intensive care unit (ICU), and home care settings. Stryker offers a comprehensive portfolio that includes:
Orthopaedics
Stryker’s Orthopaedics segment is dedicated to developing innovative, high-quality products that help patients regain mobility and resume their daily lives. With a strong foundation in clinical expertise and product innovation, the company remains at the forefront of musculoskeletal care.
Key areas within this segment include:
Neurotechnology & Spine
Stryker also provides specialized solutions through its Neurotechnology & Spine segment, which supports neurosurgical and spinal interventions with advanced tools and systems. This business area leverages technological innovation to help surgeons address complex neurological and spinal conditions.
This segment includes:
|
Product |
Product Description |
|
Radiofrequency Ablation System |
Designed for reliability, efficiency, and ultimate control and customization, the Performance Platform offers a distinct advantage for both healthcare professionals and their patients. It includes the MultiGen 2 radiofrequency generator, which, in combination with the Venom cannula and electrode system, delivers large, minimally invasive lesions in a short amount of time. MultiGen 2 radiofrequency generator Engineered for exceptional reliability, efficiency, and control, the Performance Platform enhances the experience for both practitioners and patients. Features Double the Confidence: With 100 watts of power, the MultiGen 2 RF generator quickly reaches the target temperature, optimizing time. It ensures exceptional quality and durability, while offering peace of mind through ProCare Services’ overnight replacement program. Customized to Individual Needs: The system allows for faster temperature ramp-up and features a simplified interface. It enables the creation of strip lesions for the SI joint without removing electrodes. The MultiGen 2 RF generator includes modern features such as an ultra-responsive touchscreen, a USB port for saving and transferring presets, and a lifecycle tracker for electrode use. Take Control: Healthcare professionals can select the order of lesions with independently controlled channels. Flexible stimulation controls allow procedures to be performed at the operator’s preferred pace. The MultiGen 2 RF generator can be customized based on patient needs, procedural goals, and individual preferences. Standard cannulae and electrodes The MultiGen 2 Radiofrequency Generator is compatible with a wide variety of cannulae and electrodes. It intelligently recognizes the selected electrode, adjusts its heating accordingly, and automatically differentiates whether the procedure is monopolar. Cannulae Features:
Nitinol Electrodes:
Venom Cannula and Electrode System Powered by the MultiGen 2 radiofrequency generator, the Venom system creates large lesions in a short time. Venom System Features: Large Lesion, Small Footprint: The 20-gauge Venom cannula creates lesions that are 92% larger than those produced with the standard configuration. Industry-Leading Reliability: Probes are validated for a minimum of 520 sterilization cycles. Efficient Anesthesia Delivery: The cannula’s side port allows for the immediate propagation of fluid near the exposed tip, potentially providing more efficient anesthesia delivery to the targeted lesion zone. |
Stryker’s strategy in the North America Radiofrequency Ablation (RFA) for Pain Management market is centered on innovation, strategic expansion, and localized execution. The company invests significantly in research and development to deliver cutting-edge, minimally invasive pain management technologies, supported by a robust global patent portfolio of over 12,900 patents.
By continuously developing advanced RFA systems and integrating them with imaging and surgical solutions, Stryker aims to improve procedural precision and patient outcomes. Strategic acquisitions and partnerships play a key role in expanding its product portfolio, particularly in neurotechnology, robotics, and surgical instrumentation, which complement and enhance its RFA offerings.
North America remains a focal market, where rising chronic pain cases and the demand for outpatient procedures present significant growth opportunities. Leveraging its extensive U.S.-based infrastructure and strong clinical partnerships, Stryker ensures rapid innovation deployment and practitioner education.
While global in reach, the company tailors its strategy to meet the specific needs of North American providers, reinforcing its leadership in non-opioid, minimally invasive pain treatment solutions.
Need a tailored company profile or competitive intelligence report? Our analysts are ready to help.
Contact Our ExpertsExplore all published company profiles across 30+ industry verticals.
View All Profiles